Role of Nitric Oxide in Ginsenoside Rg1-Induced Protection against Left Ventricular Hypertrophy Produced by Abdominal Aorta Coarctation in Rats

概要

論文の詳細を見る
Ginsenoside Rg1 (Rg1), one of the active components of Panax ginseng, has been reported to promote endogenous nitric oxide (NO) production in some tissues, and to inhibit left ventricular (LV) hypertrophy in rats. This study aimed to investigate whether Rg1-induced inhibition of rat LV hypertrophy is mediated by NO-production. Rat LV hypertrophy was induced by abdominal aorta coarctation. Rg1 15 mg/kg/d, L-arginine 200 mg/kg/d, and the nitric oxide synthase (NOS) inhibitor NG-nitro-L-arginine-methyl ester (L-NAME) 100 mg/kg/d used with the same dose of L-arginine or Rg1 were given starting from 1 d after surgery for 21 consecutive days. LV hypertrophy was evidenced by determining LV weight and mRNA expression of atrial natriuretic peptide, a marker of cardiac hypertrophic response, as well as by histopathology. Rg1 and L-arginine administration significantly reduced the elevated LV hypertrophic parameters independent of LV systolic pressure changing, and ameliorated the histopathology of LV myocardium and LV diastolic function. All the beneficial effects of Rg1 and L-arginine were abolished or blunted by L-NAME. Further to examine the role of NO in Rg1 inhibition on LV hypertrophy, expression of endothelial NOS was determined at the transcript levels. In our experimental conditions endothelial NOS mRNA expression in LV tissue was lowered by abdominal aorta coarctation, and upregulated by Rg1 administration. These results demonstrate that Rg1-induced protection against LV hypertrophy elicited by abdominal aorta coarctation in rats is mediated, at least in part, via endogenous NO production and release.

Role of Nitric Oxide in Ginsenoside Rg1-Induced Protection against Left Ventricular Hypertrophy Produced by Abdominal Aorta Coarctation in Rats

スポンサーリンク

概要

著者

関連論文

スポンサーリンク